Fontaine-Sylvestre, Cédric
Létourneau-Guillon, Laurent
Moumdjian, Robert A.
Berthelet, France
Lacroix, André http://orcid.org/0000-0003-4137-3025
Article History
Accepted: 13 October 2020
First Online: 19 October 2020
Compliance with ethical standards
:
: AL received funding as an investigator for participation in the LINC-3 trial from Novartis.
: LINC-3 study was approved by the CHUM ethics committee.
: Patient provided informed signed consent to participate in the study and to publish results.